Elena Nikulina

Candel Therapeutics, Inc. celebrates Susan Stewart recognition in RAPSorg milestone honors

Candel Therapeutics, Inc. celebrates Susan Stewart recognition in RAPSorg milestone honors
Candel executive named in RAPSorg list

Candel Therapeutics, Inc. announced that its Chief Regulatory Officer, Susan Stewart, J.D., has been named to the RAPSorg 50 for 50 list, which honors outstanding regulatory professionals as part of the Regulatory Affairs Professionals Society’s 50th anniversary.

The company praised Stewart’s expertise as a critical factor in advancing its regulatory strategy. RAPSorg’s annual recognition highlights the industry’s leading experts in regulatory affairs, underscoring the importance of leadership in advancing healthcare compliance and innovation.

Candel Therapeutics has recently advanced its focus on viral immunotherapies targeting prostate, lung, and brain cancers, according to a research update. The company’s leadership has also advocated for development of targeted oncology therapies in industry discussions. These efforts align with the company’s ongoing commitment to scientific and regulatory progress.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.